NEW YORK, Jan. 10—Genomic Solutions has amended its distribution deal with PerkinElmer Life Sciences, the company said Thursday.
Under the new agreement, PerkinElmer will have non-exclusive rights to market and distribute all Genomic Solutions products outside the U.S. and Japan, and assumes non-exclusive distribution rights worldwide for Genomic Solution's Investigator proteomic electrophoresis products. the company's GeneTAC HybStation, and all Cartesian Technologies products.
The two companies have had a comprehensive sales, distribution, and technology alliances since December 1999, when PerkinElmer made an equity investment in the company. After settling a lawsuit regarding that equity stake in spring 2001, the firms expanded that arrangement.